Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: AstraZeneca
Healthy Participants · Dyslipidemia
United States
- A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Breast Cancer
United States, Australia, Austria, Belgium, Brazil +21 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
France
- Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in GermanyActive Not Recruiting
Sponsor: AstraZeneca
Heart Diseases · Cardiovascular Diseases · Heart Failure
Germany
Sponsor: AstraZeneca
Solid Tumours
Australia, Georgia, Poland, South Korea, Taiwan
- A Study to Investigate the Effect of AZD5004 on Mitiglinide and Pioglitazone in Healthy ParticipantsCompleted
Sponsor: AstraZeneca
Healthy Participants
Japan
Sponsor: AstraZeneca
B-cell Acute Lymphoblastic Leukemia (B-ALL)
United States, Australia, Canada, China, Japan +4 more
Sponsor: AstraZeneca
Weight Management
United States, Argentina, Australia, Brazil, Canada +14 more
- Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung CancerActive Not Recruiting
Sponsor: Muhammad Furqan
Extensive Stage Small Cell Lung Cancer
United States
- Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian CancerActive Not Recruiting
Sponsor: AstraZeneca
Ovarian Cancer
Germany
- A Phase III Study to Evaluate the Efficacy and Safety of Benralizumab in Patients With Hypereosinophilic Syndrome (HES)Active Not Recruiting
Sponsor: AstraZeneca
Hypereosinophilic Syndrome
United States, Argentina, Austria, Belgium, China +12 more
- Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain MetastasesActive Not Recruiting
Sponsor: Colette Shen
Breast Cancer · Brain Metastases, Adult
United States
- Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene AlterationsActive Not Recruiting
Sponsor: Rana McKay, MD
Prostate Cancer · BRCA1 Mutation · BRCA2 Mutation · Prostatic Adenocarcinoma
United States
- A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsActive Not Recruiting
Sponsor: AstraZeneca
Part 1: Bladder, Biliary Tract, Cervical, Endometrial, Ovarian, Pancreatic Cancer, Rare Tumors, Any Tumor Type Excluding Breast, Gastric, Colorectal Cancer · Part 2: HER2 Expressing/Amplified Solid Tumors Excluding Breast, Gastric, Colorectal Cancer
United States, Australia, Belgium, Brazil, Canada +12 more
Sponsor: AstraZeneca
Locally Advanced or Metastatic Non-Small Cell Lung Cancer
United States, Austria, Belgium, Brazil, Canada +15 more
- Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01)Active Not Recruiting
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, Australia, Belgium, Brazil, Canada +16 more
Sponsor: AstraZeneca
Gastric Cancer
United States, Brazil, Canada, China, Germany +9 more
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentNot Yet Recruiting
Sponsor: AstraZeneca
Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus
United States, Austria, Belgium, Brazil, Bulgaria +17 more
- A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid TumorsRecruiting
Sponsor: Daiichi Sankyo
Recurrent or Metastatic Solid Tumors
United States, Brazil, France, Japan, South Korea +2 more
Sponsor: AstraZeneca
Gastric Cancer · Gastroesophageal Junction Cancer
United States, Brazil, Canada, China, France +14 more
Sponsor: AstraZeneca
Arterial Hypertension, Chronic Kidney Disease
Russia
Sponsor: AstraZeneca
Healthy Participants
Germany, United Kingdom
Sponsor: AstraZeneca
Lung Neoplasms
Canada
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Russia
- Study of Patient With Frequent COPD ExacerbationsActive Not Recruiting
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
Russia